Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease

Yulia Chernykh, Anatoly Golenkov, MD, Lyudmila Vysotskaya, Sain Shushanov, Ekaterina Rybalkina

Blood (2016) 128 (22): 5144.

https://doi.org/10.1182/blood.V128.22.5144.5144

Published: 2016

Journal Articles

Effect of Expression of Multidrug Resistance Genes on Efficacy the Treatment of Multiple Myeloma By Proteasome Inhibitor

Yulia Chernykh, Anatoly Golenkov, MD

Blood (2015) 126 (23): 4859.

https://doi.org/10.1182/blood.V126.23.4859.4859

Published: 2015

Journal Articles

Multidrug Resistance Gene (MDR1) Polymorphism and Response to Nilotinib in Egyptian Patients with Chronic Myeloid Leukemia (CML)

Mervat Mattar, MD PhD, Hend Ellithy, MSc,PhD, Yasser Elnahas, MD, Mohamed osman Azzazi, MD PhD

Blood (2014) 124 (21): 5220.

https://doi.org/10.1182/blood.V124.21.5220.5220

Published: 2014

Journal Articles

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Jacob Vine, medical student, Sara Bar Cohen, PhD, Rosa Ruchlemer, Neta Goldschmidt, MD, Moshe Levin, MD, Diana Libster, MD, Alexander Gural, MD, Moshe E. Gatt, MD, David Lavie, MD, Dina Ben-Yehuda, MD, Deborah Rund, MD

Blood (2012) 120 (21): 1340.

https://doi.org/10.1182/blood.V120.21.1340.1340

Published: 2012

Journal Articles

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Ahmet Emre Eskazan, Suzin Catal Tatonyan, Ayse Salihoglu, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, A. Burhan Ferhanoglu, Nukhet Tuzuner, Yildiz Aydin, Ugur Ozbek, Teoman Soysal

Blood (2011) 118 (21): 1692.

https://doi.org/10.1182/blood.V118.21.1692.1692

Published: 2011

Journal Articles

Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib

Wendy Deenik, Bronno van der Holt, Jeroen J. W. M. Janssen, Isabel W. T. Chu, Peter J. M. Valk, Gert J. Ossenkoppele, Ilse P. van der Heiden, Pieter Sonneveld, Ron H. N. van Schaik, Jan J. Cornelissen

Blood (2010) 116 (26): 6144–6145.

https://doi.org/10.1182/blood-2010-07-296954

Published: 2010

Journal Articles

Response: is there really a relationship between Multidrug Resistance Gene ( MDR1 ) polymorphisms and major molecular response to imatinib in chronic myeloid leukemia?

Stéphanie Dulucq, Claude Preudhomme, François Guilhot, François-Xavier Mahon

Blood (2010) 116 (26): 6145–6146.

https://doi.org/10.1182/blood-2010-08-298794

Published: 2010

Journal Articles

The Impact of FLT3-ITD Mutation on the Expression of Multidrug Resistance Genes MDR-1, MRP-1, BCRP and LRP In Adult Acute Myeloid Leukemia

Barbara Nasilowska-Adamska, Iwona Solarska, Bozena Marianska, Krzysztof Warzocha, Prof, MD, PhD

Blood (2010) 116 (21): 1808.

https://doi.org/10.1182/blood.V116.21.1808.1808

Published: 2010

Journal Articles

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

Christian Steidl, Adele Telenius, Sohrab P. Shah, Pedro Farinha, Lorena Barclay, Merrill Boyle, Joseph M. Connors, Douglas E. Horsman, Randy D. Gascoyne

Blood (2010) 116 (3): 418–427.

https://doi.org/10.1182/blood-2009-12-257345

Published: 2010

Includes: Supplemental data

Journal Articles

Polymorphisms in the Multidrug Resistance Gene MDR1 (ABCB1) Predict for Molecular Resistance in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) Receiving High-Dose Imatinib.

Wendy Deenik, MD, Bronno van der Holt, PhD, Jeroen JWM Janssen, MD, Isabel W.T. Chu, Peter Valk, PhD, Gert Ossenkoppele, MD, PhD, Ilse van der Heiden, Pieter Sonneveld, MD, PhD, Ron van Schaik, PhD, Jan J. Cornelissen, MD, PhD

Blood (2009) 114 (22): 2208.

https://doi.org/10.1182/blood.V114.22.2208.2208

Published: 2009

Journal Articles

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

Samuele Gherardi, Simona Soverini, Ph.D., Nunzio Iraci, Ph.D., Carolina Terragna, Ph.D., Emanuele Valli, Sandra Durante, Annalisa Astolfi, Ph.D., Roberto Bernardoni, Ph.D., Thea Kalebic, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Giovanni Perini, Ph.D.

Blood (2009) 114 (22): 3252.

https://doi.org/10.1182/blood.V114.22.3252.3252

Published: 2009

Journal Articles

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, François-Xavier Mahon

Blood (2008) 112 (5): 2024–2027.

https://doi.org/10.1182/blood-2008-03-147744

Published: 2008

Journal Articles

Multidrug Resistance Gene (MDR1) Polymorphisms May Serve as Predictors of Resistance to Imatinib in Chronic Phase Chronic Myeloid Leukemia Patients.

Simona Soverini, Sabrina Angelini, Eleonora Turrini, Alessandra Gnani, Sabrina Colarossi, Giovanni Perini, Ilaria Iacobucci, Patrizia Hrelia, Giorgio Cantelli Forti, Daniela Cilloni, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, Thea Kalebic, Giovanni Martinelli

Blood (2007) 110 (11): 1946.

https://doi.org/10.1182/blood.V110.11.1946.1946

Published: 2007

Journal Articles

Poor Survival of CD34 Positive and CD13/33 Positive Patients in Pediatric T-Cell Acute Lymphoblastic Leukemia Is Not Explained by Expression of Multidrug Resistance Genes.

Martine van Grotel, MSc, Max M. van Noesel, MD,PhD, M.M. Van Den Heuvel, MD,PhD, Rob Pieters, MD,PhD, Jules P.P. Meijerink, PhD

Blood (2007) 110 (11): 4219.

https://doi.org/10.1182/blood.V110.11.4219.4219

Published: 2007

Journal Articles

Direct and Coordinate Regulation of Multidrug Resistance Genes by the c-Myc Oncoprotein.

Antonio Porro, Simona Soverini, Daniel Diolaiti, Tiziana Grafone, Emanuela Ottaviani, Nunzio Iraci, Carolina Terragna, Thea Kalebic, Michele Baccarani, Giovanni Martinelli, Giuliano Della Valle, Giovanni Perini

Blood (2006) 108 (11): 2594.

https://doi.org/10.1182/blood.V108.11.2594.2594

Published: 2006

Journal Articles

Prognostic Significance of Multidrug Resistance Gene 1 (MDR1), Multidrug Resistance-Related Protein (MRP) and Lung Resistance Protein (LRP) mRNA Expression in Acute Leukemia.

Hee Jin Huh, Chan-Jeoung Park, Seongsoo Jang, Eul-Ju Seo, Hyun-Sook Chi, Je-Hwan Lee, Kyoo-Hyung Lee, Jong Jin Seo, Hyung Nam Moon, Thad Ghim

Blood (2005) 106 (11): 4418.

https://doi.org/10.1182/blood.V106.11.4418.4418

Published: 2005

Journal Articles

Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease.

Meirav Kedmi, MD, Sara Bar Cohen, PhD, Michelle Hauzi, RN, Shlomo Maayan, MD, Deborah Rund, MD

Blood (2005) 106 (11): 1434.

https://doi.org/10.1182/blood.V106.11.1434.1434

Published: 2005

Journal Articles

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Pamela S. Becker, MD, PhD, Ying Ping Yu, MD, Ann Marie Ceredona, MT, MA, William V. Walsh, MD, Judith L. O’Donnell, BS, RN, Christopher Baum, MD, Lynn Kallander, BS, Philip A. Lowry, MD, T. J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD

Blood (2004) 104 (11): 5278.

https://doi.org/10.1182/blood.V104.11.5278.5278

Published: 2004

NARROW

Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease

Effect of Expression of Multidrug Resistance Genes on Efficacy the Treatment of Multiple Myeloma By Proteasome Inhibitor

Multidrug Resistance Gene (MDR1) Polymorphism and Response to Nilotinib in Egyptian Patients with Chronic Myeloid Leukemia (CML)

Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib

Response: is there really a relationship between Multidrug Resistance Gene ( MDR1 ) polymorphisms and major molecular response to imatinib in chronic myeloid leukemia?

The Impact of FLT3-ITD Mutation on the Expression of Multidrug Resistance Genes MDR-1, MRP-1, BCRP and LRP In Adult Acute Myeloid Leukemia

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome

Polymorphisms in the Multidrug Resistance Gene MDR1 (ABCB1) Predict for Molecular Resistance in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) Receiving High-Dose Imatinib.

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Multidrug Resistance Gene (MDR1) Polymorphisms May Serve as Predictors of Resistance to Imatinib in Chronic Phase Chronic Myeloid Leukemia Patients.

Poor Survival of CD34 Positive and CD13/33 Positive Patients in Pediatric T-Cell Acute Lymphoblastic Leukemia Is Not Explained by Expression of Multidrug Resistance Genes.

Direct and Coordinate Regulation of Multidrug Resistance Genes by the c-Myc Oncoprotein.

Prognostic Significance of Multidrug Resistance Gene 1 (MDR1), Multidrug Resistance-Related Protein (MRP) and Lung Resistance Protein (LRP) mRNA Expression in Acute Leukemia.

Drug Metabolism and Disposition Genes in Israeli HIV Patients: MDR1 and CYP3A4 Polymorphisms May Affect Susceptibility to HIV but Not the Course of the Disease.

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only